Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 185

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Amyloid beta peptide 1–42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures

Ferreira, I.L., Bajouco, L.M., Mota, S.I., Auberson, Y.P., Oliveira, C.R., Rego, A.C.·2012·Cell Calcium

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ceca.2011.11.008

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Research works printed but not linked: 46

  1. Brookmeyer, 2007, Forecasting the global burden of Alzheimer's disease, Alzheimers Dement, 3, 186, 10.1016/j.jalz.2007.04.381 · DOI · Paper page
  2. Hardy, 2002, The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics, Science, 297, 353, 10.1126/science.1072994 · DOI · Paper page
  3. Selkoe, 2001, Notch, and the genesis and treatment of Alzheimer's disease, Proc. Natl. Acad. Sci. U.S.A., 98, 11039, 10.1073/pnas.211352598 · DOI · Paper page
  4. Mattson, 1992, beta-Amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity, J. Neurosci., 12, 376, 10.1523/JNEUROSCI.12-02-00376.1992 · DOI · Paper page
  5. Kelly, 2006, beta-Amyloid-induced dynamin 1 degradation is mediated by N-methyl-d-aspartate receptors in hippocampal neurons, J. Biol. Chem., 281, 28079, 10.1074/jbc.M605081200 · DOI · Paper page
  6. Pellistri, 2008, Nonspecific interaction of prefibrillar amyloid aggregates with glutamatergic receptors results in Ca2+ increase in primary neuronal cells, J. Biol. Chem., 283, 29950, 10.1074/jbc.M803992200 · DOI
  7. Bezprozvanny, 2008, Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease, Trends Neurosci., 31, 454, 10.1016/j.tins.2008.06.005 · DOI · Paper page
  8. Parameshwaran, 2008, Amyloid beta peptides and glutamatergic synaptic dysregulation, Exp. Neurol., 210, 7, 10.1016/j.expneurol.2007.10.008 · DOI · Paper page
  9. Deshpande, 2009, A role for synaptic zinc in activity-dependent Abeta oligomer formation and accumulation at excitatory synapses, J. Neurosci., 29, 4004, 10.1523/JNEUROSCI.5980-08.2009 · DOI · Paper page
  10. Deshpande, 2006, Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons, J. Neurosci., 26, 6011, 10.1523/JNEUROSCI.1189-06.2006 · DOI · Paper page
  11. Yan, 2006, Abeta42 is more rigid than Abeta40 at the C terminus: implications for Abeta aggregation and toxicity, J. Mol. Biol., 364, 853, 10.1016/j.jmb.2006.09.046 · DOI · Paper page
  12. Johansson, 2006, Modelling of amyloid beta-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats, Exp. Brain Res., 168, 11, 10.1007/s00221-005-0069-z · DOI
  13. Goto, 2006, Amyloid beta-peptide preconditioning reduces glutamate-induced neurotoxicity by promoting endocytosis of NMDA receptor, Biochem. Biophys. Res. Commun., 351, 259, 10.1016/j.bbrc.2006.10.030 · DOI
  14. Cull-Candy, 2001, NMDA receptor subunits: diversity, development and disease, Curr. Opin. Neurobiol., 11, 327, 10.1016/S0959-4388(00)00215-4 · DOI · Paper page
  15. Cull-Candy, 2004, Role of distinct NMDA receptor subtypes at central synapses, Sci. STKE, 10.1126/stke.2552004re16 · DOI · Paper page
  16. Kohr, 2006, NMDA receptor function: subunit composition versus spatial distribution, Cell Tissue Res., 326, 439, 10.1007/s00441-006-0273-6 · DOI · Paper page
  17. Hardingham, 2009, Coupling of the NMDA receptor to neuroprotective and neurodestructive events, Biochem. Soc. Trans., 37, 1147, 10.1042/BST0371147 · DOI · Paper page
  18. Krapivinsky, 2003, The NMDA receptor is coupled to the ERK pathway by a direct interaction between NR2B and RasGRF1, Neuron, 40, 775, 10.1016/S0896-6273(03)00645-7 · DOI · Paper page
  19. Mattson, 2003, Neuronal and glial calcium signaling in Alzheimer's disease, Cell Calcium, 34, 385, 10.1016/S0143-4160(03)00128-3 · DOI · Paper page
  20. Green, 2008, Linking calcium to Abeta and Alzheimer's disease, Neuron, 59, 190, 10.1016/j.neuron.2008.07.013 · DOI · Paper page
  21. Agostinho, 2003, Involvement of calcineurin in the neurotoxic effects induced by amyloid-beta and prion peptides, Eur. J. Neurosci., 17, 1189, 10.1046/j.1460-9568.2003.02546.x · DOI
  22. Ferreiro, 2006, An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity, Neurobiol. Dis., 23, 669, 10.1016/j.nbd.2006.05.011 · DOI · Paper page
  23. Kurup, 2010, Abeta-mediated NMDA receptor endocytosis in Alzheimer's disease involves ubiquitination of the tyrosine phosphatase STEP61, J. Neurosci., 30, 5948, 10.1523/JNEUROSCI.0157-10.2010 · DOI · Paper page
  24. Auberson, 2002, 5-Phosphonomethylquinoxalinediones as competitive NMDA receptor antagonists with a preference for the human 1A/2A, rather than 1A/2B receptor composition, Bioorg. Med. Chem. Lett., 12, 1099, 10.1016/S0960-894X(02)00074-4 · DOI · Paper page
  25. Frizelle, 2006, Mol. Pharmacol., 70, 1022, 10.1124/mol.106.024042 · DOI
  26. Williams, 1993, Ifenprodil discriminates subtypes of the N-methyl-d-aspartate receptor: selectivity and mechanisms at recombinant heteromeric receptors, Mol. Pharmacol., 44, 851, 10.1016/S0026-895X(25)13275-6 · DOI · Paper page
  27. Zhou, 2006, Developmental changes in NMDA neurotoxicity reflect developmental changes in subunit composition of NMDA receptors, J. Neurosci., 26, 2956, 10.1523/JNEUROSCI.4299-05.2006 · DOI · Paper page
  28. Giacomello, 2007, Mitochondrial Ca2+ as a key regulator of cell life and death, Cell Death Differ., 14, 1267, 10.1038/sj.cdd.4402147 · DOI · Paper page
  29. LaFerla, 2002, Calcium dyshomeostasis and intracellular signalling in Alzheimer's disease, Nat. Rev. Neurosci., 3, 862, 10.1038/nrn960 · DOI · Paper page
  30. Demuro, 2005, Optical single-channel recording: imaging Ca2+ flux through individual ion channels with high temporal and spatial resolution, J. Biomed. Opt., 10, 11002, 10.1117/1.1846074 · DOI
  31. Demuro, 2005, Calcium dysregulation and membrane disruption as a ubiquitous neurotoxic mechanism of soluble amyloid oligomers, J. Biol. Chem., 280, 17294, 10.1074/jbc.M500997200 · DOI · Paper page
  32. Jan, 2011, Abeta42 neurotoxicity is mediated by ongoing nucleated polymerization process rather than by discrete Abeta42 species, J. Biol. Chem., 286, 8585, 10.1074/jbc.M110.172411 · DOI · Paper page
  33. Tovar, 1999, The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro, J. Neurosci., 19, 4180, 10.1523/JNEUROSCI.19-10-04180.1999 · DOI · Paper page
  34. Texido, 2011, Amyloid beta peptide oligomers directly activate NMDA receptors, Cell Calcium, 10.1016/j.ceca.2011.02.001 · DOI · Paper page
  35. Domingues, 2007, Toxicity of beta-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-d-aspartate receptor subunits, Neurochem. Int., 50, 872, 10.1016/j.neuint.2007.03.001 · DOI
  36. Brito-Moreira, 2011, Abeta oligomers induce glutamate release from hippocampal neurons, Curr. Alzheimer Res., 10.2174/156720511796391917 · DOI
  37. Alberdi, 2010, Amyloid beta oligomers induce Ca2+ dysregulation and neuronal death through activation of ionotropic glutamate receptors, Cell Calcium, 47, 264, 10.1016/j.ceca.2009.12.010 · DOI · Paper page
  38. Szegedi, 2005, Divergent effects of Abeta1–42 on ionotropic glutamate receptor-mediated responses in CA1 neurons in vivo, Brain Res., 1062, 120, 10.1016/j.brainres.2005.09.014 · DOI
  39. Papadia, 2007, The dichotomy of NMDA receptor signaling, Neuroscientist, 13, 572, 10.1177/1073858407305833 · DOI
  40. Goebel-Goody, 2009, Phospho-regulation of synaptic and extrasynaptic N-methyl-d-aspartate receptors in adult hippocampal slices, Neuroscience, 158, 1446, 10.1016/j.neuroscience.2008.11.006 · DOI · Paper page
  41. Steigerwald, 2000, C-Terminal truncation of NR2A subunits impairs synaptic but not extrasynaptic localization of NMDA receptors, J. Neurosci., 20, 4573, 10.1523/JNEUROSCI.20-12-04573.2000 · DOI · Paper page
  42. von Engelhardt, 2007, Excitotoxicity in vitro by NR2A- and NR2B-containing NMDA receptors, Neuropharmacology, 53, 10, 10.1016/j.neuropharm.2007.04.015 · DOI
  43. Thomas, 2006, Synaptic and extrasynaptic NMDA receptor NR2 subunits in cultured hippocampal neurons, J. Neurophysiol., 95, 1727, 10.1152/jn.00771.2005 · DOI · Paper page
  44. Harris, 2007, Extrasynaptic and synaptic NMDA receptors form stable and uniform pools in rat hippocampal slices, J. Physiol., 584, 509, 10.1113/jphysiol.2007.137679 · DOI · Paper page
  45. Martel, 2009, In developing hippocampal neurons, NR2B-containing N-methyl-d-aspartate receptors (NMDARs) can mediate signaling to neuronal survival and synaptic potentiation, as well as neuronal death, Neuroscience, 158, 334, 10.1016/j.neuroscience.2008.01.080 · DOI
  46. Soriano, 2006, Preconditioning doses of NMDA promote neuroprotection by enhancing neuronal excitability, J. Neurosci., 26, 4509, 10.1523/JNEUROSCI.0455-06.2006 · DOI · Paper page

Cited by

See all 185

Metadata

Authors
Ferreira, I. L., Bajouco, L. M., Mota, S. I., Auberson, Y. P., Oliveira, C. R., & Rego, A. C.
Venue
Cell Calcium
Publisher
Elsevier BV
Published
2012-02
Volume
51
Issue
2
Pages
95-106
ISSN
0143-4160 (ISSN-L)
OpenAlex
W2051690270
Cited by
185
References
11
FWCI
7.13
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.